Health Care & Life Sciences » Pharmaceuticals | SCI Pharmtech Inc.

SCI Pharmtech Inc. | Mutual Funds

Mutual Funds that own SCI Pharmtech Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
DFA Emerging Markets Core Equity Portfolio
599,312
0.75%
0
0.01%
04/30/2018
Nomura Taiwan High Dividend Fund
529,999
0.67%
529,999
7.32%
03/31/2018
DFA Emerging Markets Small Cap Series
456,395
0.56%
23,000
0.02%
01/31/2018
Hereford Funds - Firth Asian Value Fund
238,000
0.3%
116,000
1.81%
09/30/2017
RAM (Lux) Systematic Funds - Emerging Markets Equities
151,728
0.19%
-871,971
0.01%
06/30/2017
DFA Dimensional Emerging Markets Value Fund
91,000
0.11%
0
0%
01/31/2018
DFA Emerging Markets Social Core Equity Portfolio
23,000
0.03%
0
0%
04/30/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
21,266
0.03%
0
0%
12/31/2017
John Hancock II - Emerging Markets Fund
17,000
0.02%
0
0%
04/30/2018
RAM (Lux) Systematic Funds - Long/Short Emerging Markets Eq.
17,000
0.02%
-121,162
0.03%
06/30/2017

About SCI Pharmtech

View Profile
Address
No. 61, Lane 209, Haihu North Road
Taoyuan 338 56
Taiwan
Employees -
Website http://www.sci-pharmtech.com.tw
Updated 07/08/2019
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. It focuses in the research, development, process, manufacture and sale of active pharmaceutical ingredient (API), API intermediates, and special and precision chemicals. The company's products are used for anti-epilepsy, anticonvulsant, sleeping pills, anesthesia, arrhythmia, antibiotics, anti-anorexia agents, smoking cessation drug, hypertension, antiparkinsonian, diet pills, anti-AIDS, steroid, and antidepressant.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.